Related Experiment Video
Updated: Jan 8, 2026

11:36
In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones
Published on: July 25, 2019
11.3K
Targeting ubiquitination in disease and therapy
Xiaojuan Yang1,2, Tian Lan1,3, Buzhe Zhang1
1Laboratory of Hepatic AI Translation, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, 610041, China.
Signal Transduction and Targeted Therapy
|December 23, 2025
Summary
Ubiquitination, a key protein modification, regulates cell functions and homeostasis. Its dysregulation causes diseases, making it a vital target for new treatments like PROTACs.
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Biology
Background:
- Ubiquitination is a crucial posttranslational modification (PTM) involving ubiquitin attachment to proteins.
- This process is essential for cellular homeostasis and regulates diverse biological functions.
- The ubiquitination pathway offers versatile control over molecular processes but can be dysregulated in disease.
Purpose of the Study:
- To review historical developments and key milestones in ubiquitination research.
- To explore the roles of ubiquitination in health and disease, including mechanisms and regulation.
- To highlight therapeutic strategies and clinical progress targeting the ubiquitination pathway.
Main Methods:
- Literature review of ubiquitination research.
- Analysis of ubiquitination's role in various pathological conditions.
- Examination of emerging therapeutic strategies and clinical trials.
Main Results:
- Ubiquitination is fundamental to cellular processes and its dysregulation contributes to diseases like cancer and neurodegeneration.
- The review covers components, mechanisms, signaling pathways, and regulatory functions of ubiquitination.
- Emerging therapies, including PROTACs and molecular glues, show promise for disease treatment.
Conclusions:
- Understanding ubiquitination is critical for elucidating disease pathogenesis.
- Targeting the ubiquitination pathway offers novel therapeutic opportunities.
- Recent clinical research and drug development show significant progress in leveraging ubiquitination for disease treatment.
Related Concept Videos
The Proteasome
1.6K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.6K
The Proteasome
10.0K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.0K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Regulated Protein Degradation
8.7K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.7K
Regulated Protein Degradation
3.0K
3.0K
Covalently Linked Protein Regulators
8.6K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
8.6K

